Strata Critical Medical shareholders approve executive pay despite 17% opposition at annual meeting

Filed June 3, 2026 · Period ending May 28, 2026 · ~1 min read

Key Changes

• medium

  Shareholders approved executive compensation on advisory vote with 38.5M for and 8.0M against, representing 17% opposition—a notable level of dissent that may signal concerns about pay structure or levels.

  Item 5.07 verify on EDGAR →
• low

  Class II directors William Heyburn and Andrew Lauck elected to serve until 2029, though Lauck received 7.0M withheld votes (15% of votes cast) compared to Heyburn's 505K withheld.

  Item 5.07 verify on EDGAR →
• low

  Shareholders ratified Deloitte & Touche LLP as independent auditor for 2026 with 59M votes for and minimal opposition, a routine annual approval.

  Item 5.07 verify on EDGAR →